Terns Pharmaceuticals has announced the initiation of Phase 1 clinical trial of TERN-101, a farnesoid X receptor (F...
Ms Kimberly Nearing, Head of Life Sciences at Cedrus Investments (Cedrus), was invited to moderate the fi...
Reistone Biopharma Company Limited (Reistone), on 14 June 2019, announced dosing of the first patient in their Phase II ...
111, Inc., a leading integrated online and offline healthcare platform, on 13 June 2019, announced that it has signed a ...
"The Belt and Road" International Cocktail Reception of Chinese Medicine Innovation and Cooperation was held in Hon...
Sinovant Sciences announced on 13 June 2019, that its Clinical Trial Application (CTA) for lefamulin has been accepted b...
Terns Pharmaceuticals, Inc. and Shanghai Tuo Zhen Biological Technology Co., Ltd., on 13 June 2019, announced the launch...
The inaugural Global Health Forum (GHF) of Boao Forum for Asia (BFA) was held in Qingdao, China, from&nbs...
Parexel, a leader in the development of innovative new therapies to improve the world’s health has announced a str...
The "China Aged Care Industry Report, 2019-2025" report has been added to ResearchAndMarkets.com's o...
GT Healthcare Capital Partners, a life science-focused private equity partnership which specializes in capital investmen...
Deciphera Pharmaceuticals, a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug...
Sweden based Calliditas Therapeutics AB (“Calliditas”) and US based Everest Medicines II Limited (“Eve...
China based Ping An Healthcare and Technology Company Limited, the world's leading one-stop healthcare ecosystem platfor...
CStone Pharmaceuticals, on 9 June 2019, announced its global clinical collaboration with China focus with Baye...
Ascentage Pharma, a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for can...
US based BioMarin Pharmaceutical Inc. has announced that Vimizim® (elosulfase alfa) has been approved by the Nationa...
Innovent Biologics, Inc., a world-class biopharmaceutical company, presented the research data on the treatment of relap...
Global Cord Blood Corporation, China's leading provider of cord blood collection, laboratory testing, hematopo...
CStone Pharmaceuticals has announced that it has received approval to initiate clinical development in C...
RemeGen, Ltd. announced positive promising results for a Phase II clinical trial of RC48 on 4 June 2019, in Yantai,...
Medtec China 2019 will be held at Shanghai World Expo Exhibition and Convention Center September 25–27. This exhib...
DuPont Nutrition & Biosciences, a business unit of DuPont Specialty Products, is going to showcase a comprehensive p...
Biotage has announced its strategic collaboration with Shandong Yingsheng Biotechnology Co., Ltd. to develop Clinical Ma...
A new global standard treatment for high-risk locally advanced nose cancer has been established based on the findings fr...
